XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Note 14 - Disclosure of Financial Instruments Not Reported at Fair Value
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

(14)

Disclosure of Financial Instruments Not Reported at Fair Value

 

GAAP requires disclosure of the fair value of financial assets and liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring basis or nonrecurring basis. The estimated fair values of Bancorp’s financial instruments not measured at fair value on a recurring or non-recurring basis follows:

 

   

Carrying

           

Fair Value Measurements Using:

 

March 31, 2025 (in thousands)

 

amount

   

Fair value

   

Level 1

   

Level 2

   

Level 3

 
                                         

Assets

                                       

Cash and cash equivalents

  $ 403,736     $ 403,736     $ 403,736     $     $  

HTM debt securities

    212,451       189,017       1,931       187,086        

Federal Home Loan Bank stock

    29,315       29,315             29,315        

Loans, net

    6,557,546       6,378,753                   6,378,753  

Accrued interest receivable

    27,280       27,280       27,280              
                                         

Liabilities

                                       

Non-interest bearing deposits

  $ 1,499,383     $ 1,499,383     $ 1,499,383     $     $  

Transaction deposits

    4,318,060       4,318,060             4,318,060        

Time deposits

    1,476,523       1,474,937             1,474,937        

Securities sold under agreement to repurchase

    151,424       151,424             151,424        

Federal funds purchased

    6,540       6,540             6,540        

Subordinated debentures

    26,806       26,327             26,327        

FHLB advances

    300,000       294,643             294,643        

Accrued interest payable

    1,973       1,973       1,973              

 

 

   

Carrying

           

Fair Value Measurements Using:

 

December 31, 2024 (in thousands)

 

Amount

   

Fair Value

   

Level 1

   

Level 2

   

Level 3

 
                                         

Assets

                                       

Cash and cash equivalents

  $ 291,020     $ 291,020     $ 291,020     $     $  

HTM debt securities

    370,171       341,357       153,108       188,249        

Federal Home Loan Bank stock

    21,603       21,603             21,603        

Loans, net

    6,433,459       6,256,752                   6,256,752  

Accrued interest receivable

    27,697       27,697       27,697              
                                         

Liabilities

                                       

Non-interest bearing deposits

  $ 1,456,138     $ 1,456,138     $ 1,456,138     $     $  

Transaction deposits

    4,472,475       4,472,475             4,472,475        

Time deposits

    1,237,788       1,236,463             1,236,463        

Securities sold under agreement to repurchase

    162,967       162,967             162,967        

Federal funds purchased

    6,525       6,525             6,525        

Subordinated debentures

    26,806       26,346             26,346        

FHLB advances

    300,000       294,848             294,848        

Accrued interest payable

    1,912       1,912       1,912              

 

Fair value estimates are made at a specific point in time based on relevant market information and information about financial instruments. Because no market exists for a significant portion of Bancorp’s financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Therefore, calculated fair value estimates in many instances cannot be substantiated by comparison to independent markets and, in many cases, may not be realizable in a current sale of the instrument. Changes in assumptions could significantly impact estimates.